OBJECTIVE: To review the research progress of the feasibility of a new treatment method for atrophic rhinitis (ATR) based on tissue engineering technology (seed cells, scaffold materials, and growth factors), and provide new ideas for the treatment of ATR. METHODS: The literature related to ATR was extensively reviewed. Focusing on the three aspects of seed cells, scaffold materials, and growth factors, the recent research progress of ATR treatment was reviewed, and the future directions of tissue engineering technology to treat ATR were proposed. RESULTS: The pathogenesis and etiology of ATR are still unclear, and the effectiveness of the current treatments are still unsatisfactory. The construction of a cell-scaffold complex with sustained and controlled release of exogenous cytokines is expected to reverse the pathological changes of ATR, promoting the regeneration of normal nasal mucosa and reconstructing the atrophic turbinate. In recent years, the research progress of exosomes, three-dimensional printing, and organoids will promote the development of tissue engineering technology for ATR. CONCLUSION Tissue engineering technology can provide a new treatment method for ATR.
Humans ; Tissue Engineering/methods* ; Tissue Scaffolds ; Rhinitis, Atrophic ; Printing, Three-Dimensional ; Cytokines

Thermal conditions are an important environmental factor in maintaining healthy pigs because they affect feed intake, growth efficiency, reproduction and immune responses in pigs. RAVI, a regenerative far-infrared heating system, can effect pig production by emitting an optimal far-infrared wavelength. Far-infrared radiation has been reported to increase microvascular dilation and vascular flow volume. The purpose of this study was to evaluate the immunobiological differences between pigs raised with the RAVI system and the gasoline heater system. Twenty-six-week-old weaned pigs were raised in two rooms that were equipped with a RAVI system or a gasoline heater for 8 weeks. A porcine atrophic rhinitis vaccine was administered after two weeks and transcriptome analysis in whole blood were analyzed at 2-week intervals. Signaling pathway analyses of the RAVI group at 8 weeks showed the activation of pathways related to nitric oxide (NO) production. This suggests that the application of RAVI might induce the production of NO and iNOS, which are important for increasing the immune activity. Similar to the result of microarray, phenotypic changes were also observed at a later period of the experiment. The increase in body weight in the RAVI group was significantly higher than the gasoline heater group at 8 weeks. The antibody titer against the vaccine in the RAVI group was also higher than that the gasoline heater group at 4 weeks and 8 weeks. This evaluation of the use of a far-infrared heating system with pigs will be helpful for applications in the pig farm industry and pig welfare.
Agriculture ; Body Weight ; Gasoline ; Gene Expression Profiling ; Heating ; Hot Temperature ; Nitric Oxide ; Reproduction ; Rhinitis, Atrophic ; Swine

Tracheobronchopathia osteoplastica (TO) is a rare benign disease in which the anterior inner wall of the tracheobronchus changes because of abnormal chondrogenesis or ossification, while the posterior wall of the trachea is spared. The etiology is not clearly understood, but may relate with chronic infection, inflammation, and trauma. In some case studies, it has also been reported to be accompanied by other chronic diseases such as atrophic rhinitis and amyloidosis. However, Coexistence of TO and tuberculosis has rarely been reported, and has never been reported in Korea. Here, we report a case of a 70-year-old male patient who complained of hemoptysis and whose case was diagnosed as TO and pulmonary tuberculosis through bronchoscopy with bronchial washing and biopsy.
Aged ; Amyloidosis ; Biopsy ; Bronchoscopy ; Chondrogenesis ; Chronic Disease ; Hemoptysis ; Humans ; Inflammation ; Korea ; Male ; Rhinitis, Atrophic ; Trachea ; Tuberculosis ; Tuberculosis, Pulmonary*

Bordetella (B.) bronchiseptica is a causative agent of swine atrophic rhinitis that promotes colonization of the mucous membrane of the swine nasal cavity by Pasteurella (P.) multocida. Mixed infection with B. bronchiseptica and P. multocida leads to growth inhibition of pigs, resulting in significant economic loss. There are many commercial vaccines for atrophic rhinitis, including B. bronchiseptica as a killed vaccine antigen (Ag). However, the immunogenicity of killed B. bronchiseptica Ag has not yet been elucidated; therefore, this study was conducted to investigate the immunogenicity of killed B. bronchiseptica Ag and the type of immune response it induces. In vitro assays using mouse spleen cells and flow cytometry revealed that B. bronchiseptica Ag induced high proliferation capability of lymphocytes, especially B lymphocytes, and the proliferating cells showed a significant response to interleukin (IL)-2. B. bronchiseptica Ag also enhanced the production of IL-12, a representative cytokine for cell-mediated immunity. In vivo experiments using mice showed that the injection of B. bronchiseptica Ag markedly induced Ag-specific antibody. Taken together, these results indicate that B. bronchiseptica Ag has high immunogenicity by itself.
Animals ; B-Lymphocytes ; Bordetella ; Bordetella bronchiseptica* ; Coinfection ; Colon ; Flow Cytometry ; Immunity, Cellular ; Interleukin-12 ; Interleukins ; Lymphocytes ; Mice ; Mucous Membrane ; Nasal Cavity ; Pasteurella ; Rhinitis, Atrophic ; Spleen ; Swine ; Vaccines

Although inverted papilloma (IP) of the nose and paranasal sinus is a benign neoplasm, it is associated with frequent recurrence and malignant transformation. Various surgical techniques have been employed for resection of this tumor. Transnasal endoscopic medial maxillectomy (TEMM) is an effective surgical management of IP originating from the maxillary sinus. It usually removes the inferior turbinate, lateral wall of the nasal cavity, and nasolacrimal duct, and may cause adverse effects such as atrophic rhinitis, empty nose syndrome, impairment of nasal physiological function, and epiphora. Recently, however, a modified TEMM, which preserves the inferior turbinate, lateral wall of the nasal cavity, and nasolacrimal duct has been introduced. We present two cases of IP successfully treated by the modified TEMM.
Endoscopy ; Lacrimal Apparatus Diseases ; Maxillary Sinus* ; Nasal Cavity ; Nasolacrimal Duct ; Nose ; Papilloma, Inverted* ; Recurrence ; Rhinitis, Atrophic ; Turbinates

Extranodal NK/T cell lymphoma, nasal type, is a rare non-Hodgkin lymphoma originating in the nasal cavity or in the paranasal sinuses. Atrophic rhinitis is a debilitating chronic nasal mucosal disease of unknown etiology. However, there have not been any reports on the occurrence of nasal NK/T cell lymphoma in patients with atrophic rhinitis. We experienced a case of the extranodal NK/T cell lymphoma in the left nasal cavity, which had been misdiagnosed as atrophic rhinitis in a 39-year-old female. Thus, we report this rare case with a review of the literature.
Adult ; Female ; Humans ; Lymphoma* ; Lymphoma, Non-Hodgkin ; Nasal Cavity ; Paranasal Sinuses ; Rhinitis, Atrophic*

In this paper, we report a case of bilateral inferior and middle turbinate agenesis, a rare anomaly. A 27-year-old woman presented with nasal obstruction, crust formation, anosmia, and foul odors. Anterior rhinoscopic examination revealed the absence of the middle and inferior turbinates on both sides. The patient had no history of nasal or sinus surgery. She denied over having expelled anything of significance from her nasal cavity. She had no history of infectious disease-including tuberculosis and syphilis, granuolomatous diseases, sarcoids, Wegener's disease, and radiation therapy. There have been few reports on bilateral turbinate agenesis.
Adult ; Female ; Humans ; Nasal Cavity ; Nasal Obstruction ; Odors ; Olfaction Disorders ; Rhinitis ; Rhinitis, Atrophic* ; Syphilis ; Tuberculosis ; Turbinates*

In this paper, we report a case of bilateral inferior and middle turbinate agenesis, a rare anomaly. A 27-year-old woman presented with nasal obstruction, crust formation, anosmia, and foul odors. Anterior rhinoscopic examination revealed the absence of the middle and inferior turbinates on both sides. The patient had no history of nasal or sinus surgery. She denied over having expelled anything of significance from her nasal cavity. She had no history of infectious disease-including tuberculosis and syphilis, granuolomatous diseases, sarcoids, Wegener's disease, and radiation therapy. There have been few reports on bilateral turbinate agenesis.
Adult ; Female ; Humans ; Nasal Cavity ; Nasal Obstruction ; Odors ; Olfaction Disorders ; Rhinitis ; Rhinitis, Atrophic* ; Syphilis ; Tuberculosis ; Turbinates*

Rhinitis is a global problem and is defined as the presence of at least one of the following: congestion, rhinorrhea, sneezing, nasal itching, and nasal obstruction. The two major classifications are allergic and nonallergic rhinitis (NAR). Allergic rhinitis occurs when an allergen is the trigger for the nasal symptoms. NAR is when obstruction and rhinorrhea occurs in relation to nonallergic, noninfectious triggers such as change in the weather, exposure to caustic odors or cigarette smoke, barometric pressure differences, etc. There is a lack of concomitant allergic disease, determined by negative skin prick test for relevant allergens and/or negative allergen-specific antibody tests. Both are highly prevalent diseases that have a significant economic burden on society and negative impact on patient quality of life. Treatment of allergic rhinitis includes allergen avoidance, antihistamines (oral and intranasal), intranasal corticosteroids, intranasal cromones, leukotriene receptor antagonists, and immunotherapy. Occasional systemic corticosteroids and decongestants (oral and topical) are also used. NAR has 8 major subtypes which includes nonallergic rhinopathy (previously known as vasomotor rhinitis), nonallergic rhinitis with eosinophilia, atrophic rhinitis, senile rhinitis, gustatory rhinitis, drug-induced rhinitis, hormonal-induced rhinitis, and cerebral spinal fluid leak. The mainstay of treatment for NAR are intranasal corticosteroids. Topical antihistamines have also been found to be efficacious. Topical anticholinergics such as ipratropium bromide (0.03%) nasal spray are effective in treating rhinorrhea symptoms. Adjunct therapy includes decongestants and nasal saline. Investigational therapies in the treatment of NAR discussed include capsaicin, silver nitrate, and acupuncture.
Acupuncture ; Adrenal Cortex Hormones ; Allergens ; Capsaicin ; Cholinergic Antagonists ; Eosinophilia ; Estrogens, Conjugated (USP) ; Histamine Antagonists ; Humans ; Immunotherapy ; Ipratropium ; Leukotriene Antagonists ; Nasal Decongestants ; Nasal Obstruction ; Odors ; Pruritus ; Quality of Life ; Rhinitis ; Rhinitis, Allergic, Perennial ; Rhinitis, Atrophic ; Silver Nitrate ; Skin ; Smoke ; Sneezing ; Therapies, Investigational ; Tobacco Products ; Weather

Tracheobronchopathia osteochondroplastica (TO) is a rare benign disease of trachea characterized by numerous osseocartilaginous nodules protruding into the tracheobronchial lumen. The etiology of TO is unknown; however, an association with upper respiratory diseases such as atrophic rhinitis has been suggested. The authors report a case of TO with atrophic rhinitis with related literatures.
Osteochondrodysplasias ; Rhinitis, Atrophic ; Trachea ; Tracheal Diseases